Viracta Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Viracta Therapeutics, Inc.
CIK #0001061027, 0001416377
EDGAR Form CIK 2011 - 2025
10-K [0001061027]
10-Q [0001061027]
3 [0001061027]
4 [0001061027]
8-K [0001061027]
SC 13D [0001061027]
SC 13G [0001061027]
D [0001416377]
SC 13D [0001416377]
SC 13G [0001416377]
Form 13D/13G Filer Form 13D/13G Subject Filed
Forward Ventures V LP Viracta Therapeutics Inc [2025-02-14]
Forward Ventures V LP Viracta Therapeutics Inc [2024-02-13]
BlackRock Inc Viracta Therapeutics Inc [2022-07-08]
Aisling Capital IV LP Viracta Therapeutics Inc [2022-02-14]
BlackRock Inc Viracta Therapeutics Inc [2022-02-04]
Forward Ventures V LP Viracta Therapeutics Inc [2021-03-08]
LVP Life Science Ventures III LP Viracta Therapeutics Inc [2021-03-04]
Schindel Yair Chaim Sunesis Pharmaceuticals Inc [2021-03-02]
Schindel Yair Chaim Viracta Therapeutics Inc [2021-03-01]
Lytton Laurence W Sunesis Pharmaceuticals Inc [2021-01-04]
View All
Form 3/4/5 Subject 2011 - 2025
Royston IVOR
Viracta Therapeutics, Inc.
Pomerantz Roger
Rubino Stephen
Darcy Thomas E
Simon Barry J.
Barlow Jane F
Borellini Flavia
Chung Jane
Murphy Samuel Lafayette
View All
Terms | Privacy | Guide
tony@aum13f.com